HSD17B13-IN-97
HSD17B13-IN-97 (compound 4) is a potent hydroxysteroid 17ß-dehydrogenase 13 (HSD17B13) inhibitor with an IC50 value of ≤0.1 µM. HSD17B13-IN-97 has the potential for the research of Nonalcoholic fatty liver diseases (NAFLDs), nonalcoholic steatohepatitis (NASH) or or drug induced liver injury (DILI) [1].
Product Specifications
CAS Number
[2849338-44-7]
UNSPSC
12352005
Target
17β-HSD
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/hsd17b13-in-97.html
Solubility
10 mM in DMSO
Smiles
OC1=C(C(F)(F)F)N=C(C(NC2=CC=CC(N=CN3CC4=CC=CC=C4F)=C2C3=O)=O)C=C1
Molecular Formula
C22H14F4N4O3
Molecular Weight
458.37
References & Citations
[1]Joshua Odingo, et al. Hydroxypyridine hsd17b13 inhibitors and uses thereof. WO2022216626A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Browse additional items from our catalog
ATF3 (Activating Transcription Factor 3) (MaxLight 750) discontinued
MAPK11 (Mitogen-activated Protein Kinase 11, MAP Kinase 11, MAPK 11, Mitogen-activated Protein Kinase p38 beta, MAP Kinase p38 beta, p38b, Stress-activated Protein Kinase 2b, SAPK2b, p38-2, PRKM11, SAPK2, SAPK2B) (HRP)
